AMIKACIN

AMIKACIN was reported 17293 times

AMIKACIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR PSEUDOANEURYSM THROMBOSIS 11 0.4074
1 NEONATAL CANDIDA INFECTION 11 0.2558
2 MYCOBACTERIUM ABSCESSUS INFECTION 172 0.2406
3 SPUTUM DECREASED 10 0.2174
4 MYCOBACTERIAL PERITONITIS 17 0.1789
5 MYCOBACTERIUM FORTUITUM INFECTION 30 0.1622
6 MYCOBACTERIUM AVIUM COMPLEX INFECTION 399 0.1485
7 GEOTRICHUM INFECTION 31 0.1469
8 ATYPICAL MYCOBACTERIUM TEST POSITIVE 13 0.1340
9 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 28 0.1267
10 POST-TUSSIVE VOMITING 18 0.1104
11 SPUTUM INCREASED 230 0.1062
12 BRONCHOSCOPY 24 0.1013
13 OTOTOXICITY 183 0.0989
14 OVERGROWTH FUNGAL 10 0.0971
15 HEPATOSPLENIC CANDIDIASIS 14 0.0952
16 PULMONARY RESECTION 22 0.0887
17 INCREASED VISCOSITY OF BRONCHIAL SECRETION 53 0.0831
18 INFECTIVE EXACERBATION OF BRONCHIECTASIS 24 0.0782
19 DEPENDENCE ON OXYGEN THERAPY 38 0.0771
20 MYOCARDIAL CALCIFICATION 9 0.0769
21 SPUTUM RETENTION 72 0.0727
22 ENTEROBACTER PNEUMONIA 9 0.0577
23 DEVICE MAINTENANCE ISSUE 31 0.0527
24 MYCOBACTERIUM CHELONAE INFECTION 37 0.0501
25 AEROMONAS INFECTION 9 0.0476
26 PULMONARY CAVITATION 40 0.0460
27 PANCREAS TRANSPLANT REJECTION 9 0.0448
28 MYCOBACTERIUM TEST POSITIVE 9 0.0437
29 CANDIDA PNEUMONIA 14 0.0433
30 MYCOBACTERIAL INFECTION 70 0.0406
31 TRICHOSPORON INFECTION 16 0.0395
32 HERPES ZOSTER MENINGOENCEPHALITIS 14 0.0389
33 HYPERSENSITIVITY PNEUMONITIS 43 0.0378
34 PARAPSORIASIS 10 0.0372
35 NECROTISING ENTEROCOLITIS NEONATAL 15 0.0369
36 APHONIA 514 0.0368
37 MORAXELLA INFECTION 10 0.0365
38 ACINETOBACTER INFECTION 39 0.0356
39 RHINOCEREBRAL MUCORMYCOSIS 12 0.0346
40 RESPIRATORY TRACT INFECTION FUNGAL 18 0.0341
41 ATYPICAL MYCOBACTERIAL INFECTION 47 0.0332
42 SPUTUM ABNORMAL 22 0.0332
43 ASPERGILLUS TEST POSITIVE 10 0.0325
44 RESPIRATORY GAS EXCHANGE DISORDER 12 0.0323
45 SCEDOSPORIUM INFECTION 21 0.0297
46 RESPIRATORY TRACT IRRITATION 31 0.0297
47 CONGENITAL APLASIA 9 0.0289
48 OXYGEN THERAPY 47 0.0286
49 FUSARIUM INFECTION 20 0.0286
50 PAPILLOMA 9 0.0284
51 DEAFNESS NEUROSENSORY 92 0.0279
52 SYSTEMIC CANDIDA 69 0.0275
53 PATHOGEN RESISTANCE 246 0.0270
54 TRICHOGLOSSIA 11 0.0268
55 FUNGAEMIA 42 0.0267
56 CARDIAC VALVE VEGETATION 12 0.0247
57 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 10 0.0246
58 NOCARDIOSIS 62 0.0242
59 CHOROIDITIS 9 0.0241
60 PRODUCT PACKAGING DIFFICULT TO OPEN 62 0.0237
61 MULTIPLE-DRUG RESISTANCE 72 0.0232
62 WRONG DEVICE USED 15 0.0229
63 DRUG RESISTANCE 583 0.0227
64 ECTHYMA 9 0.0224
65 CANDIDA TEST POSITIVE 9 0.0215
66 SALIVARY GLAND DISORDER 10 0.0213
67 LUNG TRANSPLANT REJECTION 14 0.0212
68 BRONCHIECTASIS 141 0.0209
69 URINARY TRACT INFECTION FUNGAL 12 0.0209
70 THERAPY INTERRUPTED 1437 0.0201
71 DEAFNESS BILATERAL 34 0.0200
72 KLEBSIELLA INFECTION 100 0.0198
73 RED BLOOD CELLS URINE POSITIVE 19 0.0196
74 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 10 0.0196
75 DYSBIOSIS 16 0.0195
76 REHABILITATION THERAPY 74 0.0191
77 PSEUDOMONAS INFECTION 163 0.0190
78 SPUTUM DISCOLOURED 180 0.0190
79 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 94 0.0188
80 ENTEROCOCCAL INFECTION 91 0.0188
81 SERRATIA INFECTION 14 0.0188
82 STENOTROPHOMONAS INFECTION 25 0.0184
83 SPUTUM PURULENT 12 0.0182
84 BRAIN ABSCESS 46 0.0182
85 RETINAL ISCHAEMIA 11 0.0180
86 LUNG OPERATION 15 0.0179
87 DYSPHONIA 1046 0.0179
88 HYPERLACTACIDAEMIA 47 0.0175
89 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 106 0.0174
90 HAEMOPTYSIS 482 0.0173
91 VESTIBULAR DISORDER 21 0.0171
92 MUCORMYCOSIS 44 0.0169
93 PROTEUS INFECTION 12 0.0167
94 EMBOLIC CEREBRAL INFARCTION 11 0.0166
95 HEPATIC HAEMORRHAGE 14 0.0163
96 MENINGITIS TUBERCULOUS 9 0.0161
97 SPUTUM CULTURE POSITIVE 13 0.0160
98 SEPSIS NEONATAL 13 0.0160
99 PULMONARY PAIN 46 0.0157
100 GRANULOMATOUS LIVER DISEASE 11 0.0156
101 CANDIDA SEPSIS 14 0.0156
102 PSEUDOMONAL BACTERAEMIA 13 0.0152
103 ASPERGILLUS INFECTION 100 0.0152
104 NECROTISING COLITIS 19 0.0150
105 HAEMOPERITONEUM 12 0.0150
106 PARADOXICAL DRUG REACTION 54 0.0147
107 URETHRAL STENOSIS 10 0.0146
108 OCULAR TOXICITY 16 0.0145
109 DYSCHROMATOPSIA 12 0.0145
110 INCISION SITE PAIN 17 0.0145
111 PHYSICAL DECONDITIONING 37 0.0144
112 APLASIA 28 0.0143
113 PROPOFOL INFUSION SYNDROME 10 0.0142
114 BRONCHOPULMONARY ASPERGILLOSIS 110 0.0142
115 PERINEAL PAIN 10 0.0140
116 WOUND DRAINAGE 11 0.0139
117 DEAFNESS 361 0.0138
118 OPTIC NEUROPATHY 29 0.0137
119 PERIPHERAL NERVE INJURY 12 0.0137
120 PRODUCTIVE COUGH 647 0.0135
121 INTENSIVE CARE 19 0.0134
122 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 16 0.0133
123 LIVING IN RESIDENTIAL INSTITUTION 25 0.0133
124 PNEUMONIA PSEUDOMONAL 20 0.0130
125 BUTTERFLY RASH 13 0.0128
126 SECRETION DISCHARGE 159 0.0127
127 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 69 0.0127
128 BRONCHOSPASM 178 0.0125
129 PULMONARY NOCARDIOSIS 10 0.0121
130 HYPOFIBRINOGENAEMIA 12 0.0121
131 INTENTIONAL DOSE OMISSION 344 0.0121
132 FUNGAL SEPSIS 10 0.0120
133 PSEUDOMONAL SEPSIS 21 0.0120
134 HOSPICE CARE 117 0.0118
135 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 9 0.0118
136 BRONCHIAL SECRETION RETENTION 15 0.0118
137 QUADRIPARESIS 19 0.0114
138 LUNG ABSCESS 24 0.0114
139 DISSEMINATED TUBERCULOSIS 29 0.0113
140 TOTAL LUNG CAPACITY DECREASED 18 0.0113
141 PULMONARY FUNCTION TEST DECREASED 48 0.0110
142 DEVICE CONNECTION ISSUE 23 0.0109
143 PNEUMOCYSTIS JIROVECII INFECTION 13 0.0109
144 PNEUMONIA KLEBSIELLA 20 0.0109
145 CHRONIC RESPIRATORY FAILURE 13 0.0108
146 PNEUMONIA FUNGAL 42 0.0106
147 NEUTROPENIC COLITIS 22 0.0106
148 CENTRAL VENOUS CATHETERISATION 32 0.0106
149 HYPOPROTEINAEMIA 20 0.0105
150 NEUTROPENIC INFECTION 10 0.0104
151 NOSOCOMIAL INFECTION 23 0.0104
152 NEPHROPATHY TOXIC 117 0.0104
153 AXONAL NEUROPATHY 9 0.0103
154 CORNEAL OPACITY 14 0.0102
155 EMERGENCY CARE 31 0.0102
156 FEBRILE BONE MARROW APLASIA 43 0.0101
157 MECHANICAL VENTILATION 19 0.0100
158 ASPERGILLOSIS 13 0.0099
159 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 255 0.0099
160 TOOTH DISCOLOURATION 29 0.0099
161 SEPTIC SHOCK 424 0.0097
162 DEMYELINATING POLYNEUROPATHY 10 0.0097
163 PNEUMATOSIS INTESTINALIS 27 0.0095
164 CANDIDA INFECTION 159 0.0094
165 PSEUDOMEMBRANOUS COLITIS 21 0.0094
166 PATIENT DISSATISFACTION WITH TREATMENT 18 0.0093
167 CLOSTRIDIUM DIFFICILE COLITIS 99 0.0093
168 LUNG TRANSPLANT 33 0.0093
169 IMMUNE RECONSTITUTION SYNDROME 12 0.0093
170 HOSPITALISATION 1415 0.0092
171 DRUG ADMINISTERED IN WRONG DEVICE 9 0.0092
172 GRANULOMATOSIS WITH POLYANGIITIS 11 0.0091
173 TRACHEOSTOMY 13 0.0091
174 PULMONARY HAEMORRHAGE 71 0.0091
175 MULTIPLE ORGAN DYSFUNCTION SYNDROME 256 0.0090
176 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 21 0.0090
177 LINEAR IGA DISEASE 15 0.0090
178 ESCHERICHIA SEPSIS 26 0.0090
179 ACCIDENTAL UNDERDOSE 129 0.0090
180 FEEDING DISORDER NEONATAL 9 0.0086
181 ALLODYNIA 10 0.0086
182 RENAL TUBULAR DISORDER 24 0.0085
183 PROCALCITONIN INCREASED 10 0.0085
184 INFLAMMATORY MARKER INCREASED 42 0.0085
185 MEDICAL PROCEDURE 14 0.0084
186 CYSTIC FIBROSIS 46 0.0083
187 SOFT TISSUE INFECTION 15 0.0082
188 LARGE INTESTINE INFECTION 10 0.0081
189 PHARYNGEAL HAEMORRHAGE 10 0.0081
190 MYASTHENIA GRAVIS CRISIS 12 0.0081
191 PRODUCT PACKAGE ASSOCIATED INJURY 18 0.0081
192 CARBON DIOXIDE INCREASED 11 0.0081
193 GUILLAIN-BARRE SYNDROME 39 0.0081
194 LUNG OPACITY 21 0.0080
195 TINNITUS 364 0.0079
196 RASH MACULO-PAPULAR 176 0.0079
197 HYDROCEPHALUS 43 0.0079
198 CALCULUS URINARY 12 0.0078
199 EOSINOPHILIA 135 0.0077
200 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 25 0.0077
201 LOWER RESPIRATORY TRACT CONGESTION 13 0.0076
202 ELECTROCARDIOGRAM QT PROLONGED 271 0.0075
203 COMPUTERISED TOMOGRAM ABNORMAL 17 0.0075
204 CYSTITIS INTERSTITIAL 12 0.0075
205 LIVER ABSCESS 24 0.0074
206 INSURANCE ISSUE 113 0.0074
207 ESCHERICHIA INFECTION 60 0.0073
208 ADENOVIRUS INFECTION 21 0.0072
209 PNEUMONIA BACTERIAL 66 0.0072
210 TOXIC SKIN ERUPTION 72 0.0071
211 PERIPHERAL MOTOR NEUROPATHY 10 0.0071
212 BRONCHIAL OBSTRUCTION 10 0.0071
213 HYPERTROPHIC CARDIOMYOPATHY 11 0.0071
214 COAGULATION TIME PROLONGED 11 0.0071
215 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 10 0.0071
216 PULMONARY TOXICITY 50 0.0071
217 LYMPHADENITIS 17 0.0070
218 OROPHARYNGEAL DISCOMFORT 63 0.0070
219 HYPERCAPNIA 21 0.0070
220 HEPATOTOXICITY 155 0.0070
221 NEONATAL DISORDER 11 0.0069
222 ACUTE RESPIRATORY DISTRESS SYNDROME 121 0.0068
223 OXYGEN SATURATION DECREASED 367 0.0065
224 DEATH NEONATAL 9 0.0065
225 BACTERIAL SEPSIS 21 0.0064
226 ELECTROCARDIOGRAM T WAVE ABNORMAL 10 0.0064
227 BACTERAEMIA 76 0.0064
228 PULMONARY TUBERCULOSIS 27 0.0063
229 QUADRIPLEGIA 13 0.0063
230 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 37 0.0062
231 COUGH 1733 0.0062
232 CRYPTOCOCCOSIS 10 0.0061
233 OLIGURIA 38 0.0061
234 ABSCESS LIMB 26 0.0061
235 BILIRUBIN CONJUGATED INCREASED 14 0.0060
236 ENTEROBACTER INFECTION 10 0.0059
237 PARAINFLUENZAE VIRUS INFECTION 9 0.0059
238 CLOSTRIDIUM TEST POSITIVE 13 0.0059
239 HYPERBILIRUBINAEMIA 61 0.0059
240 HEPATOSPLENOMEGALY 15 0.0058
241 BRONCHIAL DISORDER 9 0.0058
242 MEGACOLON 9 0.0057
243 HEPATITIS FULMINANT 17 0.0057
244 CYTOLYTIC HEPATITIS 19 0.0057
245 LUNG DISORDER 280 0.0057
246 HEPATIC CYTOLYSIS 72 0.0056
247 SUFFOCATION FEELING 14 0.0056
248 HAEMODYNAMIC INSTABILITY 43 0.0056
249 HYPERACUSIS 21 0.0056
250 CLOSTRIDIAL INFECTION 19 0.0056
251 HYPERAEMIA 11 0.0056
252 UNDERWEIGHT 11 0.0056
253 OXYGEN CONSUMPTION INCREASED 13 0.0054
254 POLYNEUROPATHY 65 0.0054
255 LUNG CONSOLIDATION 15 0.0054
256 PNEUMOTHORAX 84 0.0053
257 COMPLICATIONS OF TRANSPLANTED KIDNEY 12 0.0053
258 TONGUE DISCOLOURATION 23 0.0053
259 ORGANISING PNEUMONIA 26 0.0052
260 STAPHYLOCOCCUS TEST POSITIVE 11 0.0052
261 RESPIRATORY DISTRESS 144 0.0052
262 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 39 0.0052
263 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 40 0.0051
264 PURULENCE 10 0.0051
265 DISTURBANCE IN SOCIAL BEHAVIOUR 12 0.0051
266 VOCAL CORD DISORDER 10 0.0051
267 DRY THROAT 51 0.0050
268 TOXIC EPIDERMAL NECROLYSIS 76 0.0050
269 PULMONARY MASS 74 0.0050
270 FORCED EXPIRATORY VOLUME DECREASED 14 0.0049
271 AREFLEXIA 13 0.0049
272 TYPE IV HYPERSENSITIVITY REACTION 13 0.0047
273 TOXIC ENCEPHALOPATHY 24 0.0047
274 BACTERIAL INFECTION 88 0.0047
275 HISTIOCYTOSIS HAEMATOPHAGIC 14 0.0047
276 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 45 0.0047
277 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 18 0.0047
278 DRUG INTOLERANCE 455 0.0047
279 THROAT IRRITATION 209 0.0047
280 ACUTE PULMONARY OEDEMA 26 0.0046
281 HYPOACUSIS 199 0.0046
282 HYPERTRANSAMINASAEMIA 32 0.0046
283 RESPIRATORY TRACT CONGESTION 73 0.0046
284 LONG QT SYNDROME 11 0.0046
285 OXYGEN SATURATION ABNORMAL 13 0.0046
286 EAR DISCOMFORT 47 0.0046
287 NECROTISING FASCIITIS 16 0.0045
288 BACTERIAL TEST POSITIVE 10 0.0045
289 BLOOD CREATININE DECREASED 14 0.0045
290 SUSPECTED OFF LABEL USE 20 0.0044
291 PROTEIN URINE PRESENT 22 0.0044
292 SUBCUTANEOUS ABSCESS 21 0.0044
293 RETINAL ARTERY OCCLUSION 11 0.0043
294 THROMBOCYTOPENIA 486 0.0043
295 ENCEPHALITIS 30 0.0043
296 HEPATITIS CHOLESTATIC 26 0.0043
297 OESOPHAGEAL CANDIDIASIS 17 0.0043
298 CYTOPENIA 52 0.0042
299 CANDIDIASIS 17 0.0042
300 CHOLESTASIS 81 0.0042
301 DERMATITIS EXFOLIATIVE 21 0.0042
302 ENTEROCOLITIS 24 0.0042
303 GASTROINTESTINAL OBSTRUCTION 10 0.0041
304 RALES 24 0.0041
305 ELECTROLYTE IMBALANCE 48 0.0041
306 CACHEXIA 21 0.0041
307 CYTOMEGALOVIRUS INFECTION REACTIVATION 18 0.0041
308 SKIN HYPERPIGMENTATION 35 0.0041
309 ELECTROCARDIOGRAM T WAVE INVERSION 9 0.0041
310 DYSPNOEA EXERTIONAL 153 0.0041
311 PANCYTOPENIA 227 0.0041
312 HYPERTHERMIA 31 0.0041
313 SHOCK HAEMORRHAGIC 33 0.0040
314 CHOLESTATIC LIVER INJURY 9 0.0040
315 FEBRILE NEUTROPENIA 268 0.0040
316 BONE MARROW FAILURE 82 0.0040
317 DERMATITIS EXFOLIATIVE GENERALISED 14 0.0040
318 NORMOCHROMIC NORMOCYTIC ANAEMIA 12 0.0040
319 VENOOCCLUSIVE DISEASE 10 0.0040
320 ORGAN FAILURE 16 0.0040
321 NEONATAL RESPIRATORY DISTRESS SYNDROME 14 0.0040
322 GLOSSITIS 14 0.0039
323 MULTI-ORGAN FAILURE 68 0.0039
324 LEUKOCYTOSIS 71 0.0039
325 INCREASED BRONCHIAL SECRETION 10 0.0039
326 NEUTROPHIL COUNT INCREASED 40 0.0039
327 ENDOCARDITIS 20 0.0039
328 CHEILITIS 21 0.0039
329 STAPHYLOCOCCAL SEPSIS 19 0.0038
330 COAGULOPATHY 64 0.0038
331 DEAFNESS UNILATERAL 21 0.0038
332 HYPERTONIC BLADDER 11 0.0038
333 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 208 0.0038
334 PNEUMOCYSTIS JIROVECII PNEUMONIA 38 0.0038
335 BLOOD ALBUMIN DECREASED 30 0.0038
336 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 10 0.0038
337 RESPIRATORY FAILURE 274 0.0038
338 ORAL CANDIDIASIS 49 0.0037
339 ANURIA 32 0.0037
340 CHOLANGITIS 23 0.0037
341 ADVERSE DRUG REACTION 332 0.0037
342 HAEMOLYTIC ANAEMIA 33 0.0037
343 HAEMATOLOGICAL INFECTION 9 0.0037
344 HYPERURICAEMIA 15 0.0036
345 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 10 0.0036
346 OROPHARYNGEAL PAIN 332 0.0036
347 RENAL TUBULAR NECROSIS 35 0.0036
348 LEUKOPENIA 178 0.0036
349 TRANSAMINASES INCREASED 79 0.0035
350 DRUG-INDUCED LIVER INJURY 111 0.0035
351 VASCULAR DEVICE INFECTION 16 0.0035
352 HEPATOCELLULAR INJURY 50 0.0035
353 DEVICE ISSUE 315 0.0035
354 INCORRECT PRODUCT ADMINISTRATION DURATION 76 0.0035
355 PRODUCT SUPPLY ISSUE 25 0.0035
356 ACUTE GRAFT VERSUS HOST DISEASE 16 0.0035
357 DISSEMINATED INTRAVASCULAR COAGULATION 49 0.0035
358 HYPOALBUMINAEMIA 27 0.0035
359 SKIN NECROSIS 18 0.0035
360 PRODUCT DISTRIBUTION ISSUE 32 0.0034
361 OPTIC NEURITIS 31 0.0034
362 MALNUTRITION 38 0.0034
363 GENERAL PHYSICAL CONDITION ABNORMAL 23 0.0034
364 PURPURA 30 0.0034
365 MIXED LIVER INJURY 10 0.0033
366 EAR CONGESTION 9 0.0033
367 ORAL FUNGAL INFECTION 9 0.0033
368 FAILURE TO THRIVE 17 0.0033
369 TRANSPLANT REJECTION 26 0.0032
370 HERPES SIMPLEX 21 0.0032
371 THROAT CLEARING 12 0.0032
372 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 167 0.0032
373 DRUG DOSE OMISSION BY DEVICE 250 0.0032
374 STATUS EPILEPTICUS 36 0.0032
375 PULMONARY CONGESTION 42 0.0032
376 HEPATIC NECROSIS 12 0.0032
377 GASTROINTESTINAL TOXICITY 15 0.0031
378 ACUTE RESPIRATORY FAILURE 60 0.0031
379 BLOOD UREA INCREASED 52 0.0031
380 DYSGEUSIA 230 0.0031
381 ENCEPHALOPATHY 76 0.0031
382 DRUG LEVEL BELOW THERAPEUTIC 17 0.0031
383 EPIGASTRIC DISCOMFORT 12 0.0031
384 TENDON DISORDER 20 0.0031
385 TONGUE DISCOMFORT 13 0.0031
386 ACUTE KIDNEY INJURY 465 0.0030
387 MYOPATHY 26 0.0030
388 HEPATIC LESION 13 0.0030
389 BLOOD CULTURE POSITIVE 9 0.0030
390 SHOCK 69 0.0030
391 CHOKING 58 0.0030
392 FUNGAL INFECTION 99 0.0030
393 SEPSIS 331 0.0030
394 UNEVALUABLE EVENT 224 0.0030
395 CARDIAC TAMPONADE 14 0.0029
396 DYSPNOEA 1666 0.0029
397 MYELOSUPPRESSION 105 0.0029
398 BRAIN DEATH 9 0.0029
399 LEG AMPUTATION 12 0.0029
400 REFUSAL OF TREATMENT BY PATIENT 19 0.0029
401 ILLNESS 298 0.0029
402 BLOOD LACTIC ACID INCREASED 15 0.0028
403 MACULOPATHY 10 0.0028
404 BEDRIDDEN 37 0.0028
405 NEUTROPENIC SEPSIS 20 0.0028
406 HYPERAMMONAEMIA 14 0.0028
407 RESPIRATORY ACIDOSIS 11 0.0028
408 STAPHYLOCOCCAL INFECTION 92 0.0028
409 HEPATITIS 71 0.0028
410 PATENT DUCTUS ARTERIOSUS 11 0.0028
411 LYMPHOPENIA 39 0.0028
412 DRUG LEVEL DECREASED 28 0.0027
413 SKIN PAPILLOMA 11 0.0027
414 DEVICE PHYSICAL PROPERTY ISSUE 21 0.0027
415 PERIPHERAL SENSORY NEUROPATHY 16 0.0027
416 TREATMENT FAILURE 226 0.0027
417 HYPOXIA 96 0.0027
418 OTITIS MEDIA 9 0.0027
419 DRUG LEVEL INCREASED 45 0.0027
420 LYMPHOCYTE COUNT DECREASED 48 0.0027
421 PANCREATITIS ACUTE 61 0.0027
422 HYPOVOLAEMIC SHOCK 13 0.0027
423 WOUND HAEMORRHAGE 10 0.0027
424 SALIVARY HYPERSECRETION 27 0.0027
425 NEPHRITIS 9 0.0027
426 PLEURISY 16 0.0027
427 NEUROTOXICITY 47 0.0027
428 PRODUCT DOSE OMISSION ISSUE 786 0.0027
429 HEPATOMEGALY 26 0.0026
430 RESPIRATORY SYNCYTIAL VIRUS INFECTION 23 0.0026
431 RASH PUSTULAR 19 0.0026
432 GRANULOMA 9 0.0026
433 CHEST DISCOMFORT 266 0.0026
434 CYTOKINE RELEASE SYNDROME 52 0.0026
435 ACUTE HEPATIC FAILURE 35 0.0026
436 VAGINAL INFECTION 12 0.0025
437 MENINGITIS 17 0.0025
438 RETCHING 54 0.0025
439 GRAFT VERSUS HOST DISEASE 18 0.0025
440 KIDNEY TRANSPLANT REJECTION 12 0.0025
441 TUMOUR LYSIS SYNDROME 22 0.0025
442 WHEEZING 148 0.0025
443 LUNG INFILTRATION 22 0.0025
444 BLOOD CREATINE INCREASED 11 0.0025
445 ATELECTASIS 24 0.0025
446 EMPHYSEMA 25 0.0025
447 DEVICE LEAKAGE 106 0.0024
448 ABSCESS 39 0.0024
449 HYPERKALAEMIA 85 0.0024
450 HYPERNATRAEMIA 12 0.0024
451 DEVICE RELATED INFECTION 37 0.0024
452 EAR DISORDER 11 0.0024
453 SKIN MASS 16 0.0024
454 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 12 0.0024
455 MUCOSAL INFLAMMATION 62 0.0024
456 NEUROPATHY PERIPHERAL 225 0.0024
457 OFF LABEL USE 2052 0.0023
458 JAUNDICE 63 0.0023
459 PURULENT DISCHARGE 10 0.0023
460 HAEMORRHAGE INTRACRANIAL 35 0.0023
461 PROTHROMBIN TIME PROLONGED 14 0.0023
462 CLOSTRIDIUM DIFFICILE INFECTION 51 0.0023
463 PNEUMONITIS 63 0.0023
464 DRUG ERUPTION 41 0.0023
465 CONCOMITANT DISEASE AGGRAVATED 14 0.0023
466 ALTERED STATE OF CONSCIOUSNESS 49 0.0023
467 AGRANULOCYTOSIS 42 0.0023
468 CARDIAC FAILURE ACUTE 15 0.0022
469 PRODUCT USE IN UNAPPROVED INDICATION 557 0.0022
470 CYSTITIS HAEMORRHAGIC 9 0.0022
471 BREATH SOUNDS ABNORMAL 11 0.0022
472 CARDIOGENIC SHOCK 32 0.0022
473 CYTOMEGALOVIRUS INFECTION 37 0.0022
474 RENAL IMPAIRMENT 187 0.0022
475 DRUG INTERACTION 352 0.0022
476 DERMATITIS BULLOUS 16 0.0022
477 ARTHRITIS BACTERIAL 9 0.0022
478 NEUTROPENIA 298 0.0022
479 PERITONITIS BACTERIAL 22 0.0022
480 CHOKING SENSATION 12 0.0022
481 PNEUMONIA 703 0.0022
482 EOSINOPHIL COUNT INCREASED 18 0.0022
483 HYPOMAGNESAEMIA 30 0.0022
484 CONDITION AGGRAVATED 654 0.0021
485 PHLEBITIS 11 0.0021
486 BENIGN PROSTATIC HYPERPLASIA 11 0.0021
487 METABOLIC ACIDOSIS 68 0.0021
488 HYPERPYREXIA 9 0.0021
489 ESCHERICHIA URINARY TRACT INFECTION 9 0.0021
490 PARTIAL SEIZURES 11 0.0021
491 LACTIC ACIDOSIS 68 0.0021
492 GASTROINTESTINAL DISORDER 187 0.0021
493 ALANINE AMINOTRANSFERASE INCREASED 128 0.0021
494 PRODUCT DOSE OMISSION 136 0.0021
495 TACHYPNOEA 28 0.0021
496 TORSADE DE POINTES 16 0.0020
497 BLOOD BILIRUBIN INCREASED 55 0.0020
498 PULMONARY OEDEMA 91 0.0020
499 VENOOCCLUSIVE LIVER DISEASE 10 0.0020
500 HAEMODIALYSIS 17 0.0020
501 HEPATIC FAILURE 61 0.0020
502 HYPOKALAEMIA 93 0.0020
503 ILEUS 25 0.0020
504 RESPIRATORY DISORDER 60 0.0020
505 HYPOTONIA 20 0.0020
506 RENAL FAILURE ACUTE 85 0.0020
507 CIRCULATORY COLLAPSE 34 0.0020
508 BRADYPHRENIA 13 0.0020
509 C-REACTIVE PROTEIN INCREASED 72 0.0020
510 NECROSIS 11 0.0020
511 INTRACRANIAL PRESSURE INCREASED 11 0.0020
512 COMA 94 0.0020
513 FACE OEDEMA 33 0.0020
514 TREATMENT NONCOMPLIANCE 107 0.0020
515 COVID-19 PNEUMONIA 23 0.0019
516 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 20 0.0019
517 HAEMOLYSIS 15 0.0019
518 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
519 GENERALISED OEDEMA 24 0.0019
520 GASTRITIS EROSIVE 9 0.0019
521 VENTRICULAR EXTRASYSTOLES 20 0.0019
522 RESPIRATORY RATE INCREASED 17 0.0019
523 PYREXIA 662 0.0019
524 EXERCISE TOLERANCE DECREASED 11 0.0019
525 BRAIN OEDEMA 24 0.0019
526 HYPERTRIGLYCERIDAEMIA 11 0.0019
527 RENAL FAILURE 249 0.0019
528 GAMMA-GLUTAMYLTRANSFERASE INCREASED 41 0.0018
529 PYELONEPHRITIS 16 0.0018
530 STEVENS-JOHNSON SYNDROME 41 0.0018
531 GRAND MAL CONVULSION 17 0.0018
532 ENDOPHTHALMITIS 11 0.0018
533 HYPOGAMMAGLOBULINAEMIA 12 0.0018
534 NERVOUS SYSTEM DISORDER 57 0.0018
535 BLOOD CREATININE INCREASED 119 0.0018
536 TACHYCARDIA 161 0.0018
537 ANAEMIA 344 0.0018
538 VASCULITIS 21 0.0018
539 VENTRICULAR FIBRILLATION 20 0.0018
540 ORAL DISCOMFORT 25 0.0018
541 PLEURAL EFFUSION 109 0.0018
542 SKIN LESION 49 0.0018
543 PIGMENTATION DISORDER 11 0.0018
544 HYPOTHERMIA 18 0.0018
545 DEVICE USE ISSUE 31 0.0018
546 BLOOD SODIUM DECREASED 33 0.0017
547 ASPARTATE AMINOTRANSFERASE INCREASED 93 0.0017
548 GENERAL PHYSICAL HEALTH DETERIORATION 202 0.0017
549 MYOCARDITIS 20 0.0017
550 EATING DISORDER 37 0.0017
551 APLASTIC ANAEMIA 9 0.0017
552 CYANOSIS 27 0.0017
553 BODY TEMPERATURE INCREASED 35 0.0017
554 HEPATIC FUNCTION ABNORMAL 64 0.0017
555 ACIDOSIS 13 0.0017
556 IMMUNOSUPPRESSION 15 0.0017
557 EAR PAIN 33 0.0017
558 NODULE 22 0.0017
559 RETINAL HAEMORRHAGE 12 0.0017
560 ODYNOPHAGIA 10 0.0017
561 ANAL INCONTINENCE 15 0.0017
562 LUPUS-LIKE SYNDROME 15 0.0017
563 DISEASE PROGRESSION 195 0.0016
564 LOW BIRTH WEIGHT BABY 13 0.0016
565 PHARYNGEAL SWELLING 16 0.0016
566 INTESTINAL ISCHAEMIA 9 0.0016
567 THERAPY NON-RESPONDER 73 0.0016
568 DRUG DIVERSION 10 0.0016
569 OBSTRUCTIVE AIRWAYS DISORDER 18 0.0016
570 MYASTHENIA GRAVIS 13 0.0016
571 ERYTHEMA MULTIFORME 15 0.0016
572 EPILEPSY 49 0.0016
573 EPSTEIN-BARR VIRUS INFECTION 10 0.0016
574 WEIGHT DECREASED 445 0.0016
575 WHITE BLOOD CELL COUNT INCREASED 61 0.0016
576 HYPONATRAEMIA 89 0.0016
577 MUSCULOSKELETAL CHEST PAIN 24 0.0015
578 METABOLIC DISORDER 9 0.0015
579 LIVER INJURY 38 0.0015
580 RENAL DISORDER 72 0.0015
581 LUNG INFECTION 24 0.0015
582 APNOEA 12 0.0015
583 CARDIAC ARREST 127 0.0015
584 CARDIAC OPERATION 13 0.0015
585 INABILITY TO AFFORD MEDICATION 15 0.0015
586 APPETITE DISORDER 10 0.0015
587 DECREASED APPETITE 347 0.0015
588 INFLAMMATION 77 0.0015
589 FRUSTRATION TOLERANCE DECREASED 12 0.0015
590 FEEDING DISORDER 30 0.0015
591 LARYNGEAL OEDEMA 9 0.0015
592 HAEMATURIA 50 0.0015
593 NIGHT SWEATS 47 0.0015
594 GENERALISED TONIC-CLONIC SEIZURE 24 0.0014
595 TUBULOINTERSTITIAL NEPHRITIS 27 0.0014
596 ADVERSE REACTION 19 0.0014
597 RESPIRATORY TRACT INFECTION 37 0.0014
598 DISEASE RECURRENCE 67 0.0014
599 FACIAL PARALYSIS 12 0.0014
600 ENTERITIS 9 0.0014
601 HYPERGLYCAEMIA 51 0.0014
602 DRUG INEFFECTIVE 1836 0.0014
603 PERICARDIAL EFFUSION 32 0.0014
604 FAECES SOFT 10 0.0014
605 FLUID OVERLOAD 20 0.0014
606 ASPIRATION 15 0.0014
607 INTENTIONAL UNDERDOSE 10 0.0014
608 ILL-DEFINED DISORDER 83 0.0014
609 RENAL INJURY 40 0.0013
610 DEATH 1154 0.0013
611 SINUS TACHYCARDIA 19 0.0013
612 HYDRONEPHROSIS 10 0.0013
613 VENTRICULAR TACHYCARDIA 22 0.0013
614 PREMATURE BABY 40 0.0013
615 EPISTAXIS 98 0.0013
616 LIPASE INCREASED 10 0.0013
617 LYMPHADENOPATHY 46 0.0013
618 PULMONARY HYPERTENSION 27 0.0013
619 ASTHENIA 487 0.0013
620 EYELID OEDEMA 15 0.0013
621 BLOOD ALKALINE PHOSPHATASE INCREASED 32 0.0013
622 SKIN REACTION 18 0.0013
623 BLOOD LACTATE DEHYDROGENASE INCREASED 20 0.0013
624 TRICUSPID VALVE INCOMPETENCE 10 0.0013
625 MYOCLONUS 15 0.0013
626 RHINORRHOEA 81 0.0013
627 TENDERNESS 13 0.0012
628 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 11 0.0012
629 COLITIS 47 0.0012
630 RASH ERYTHEMATOUS 59 0.0012
631 THROMBOTIC MICROANGIOPATHY 12 0.0012
632 NO THERAPEUTIC RESPONSE 15 0.0012
633 INFECTION 178 0.0012
634 MOUTH HAEMORRHAGE 9 0.0012
635 HAEMARTHROSIS 11 0.0012
636 HYPOGLYCAEMIA 59 0.0012
637 OSTEOMYELITIS 22 0.0012
638 HAEMATOCRIT DECREASED 24 0.0012
639 KETOACIDOSIS 9 0.0012
640 DERMATITIS 25 0.0012
641 PERICARDITIS 20 0.0012
642 SENSATION OF FOREIGN BODY 10 0.0012
643 PERSONALITY CHANGE 11 0.0012
644 LIVER FUNCTION TEST ABNORMAL 34 0.0012
645 RIB FRACTURE 24 0.0012
646 GASTROENTERITIS 17 0.0012
647 HYPOTENSION 233 0.0012
648 INTERNATIONAL NORMALISED RATIO INCREASED 33 0.0012
649 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 54 0.0012
650 PRODUCT PRESCRIBING ISSUE 25 0.0011
651 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 55 0.0011
652 HAEMOGLOBIN DECREASED 117 0.0011
653 HALLUCINATION, VISUAL 24 0.0011
654 TASTE DISORDER 23 0.0011
655 BRADYCARDIA 60 0.0011
656 BLOOD DISORDER 9 0.0011
657 ASCITES 33 0.0011
658 HEMIPARESIS 19 0.0011
659 SKIN DISCOLOURATION 51 0.0011
660 SURGERY 65 0.0011
661 PALLOR 30 0.0011
662 DRUG TOXICITY 15 0.0011
663 PULMONARY THROMBOSIS 12 0.0011
664 WOUND INFECTION 12 0.0011
665 EXOSTOSIS 10 0.0011
666 SEROTONIN SYNDROME 21 0.0011
667 HEPATIC ENZYME INCREASED 74 0.0011
668 MALAISE 475 0.0011
669 CHEST PAIN 200 0.0011
670 THROAT TIGHTNESS 29 0.0011
671 HEPATIC ENCEPHALOPATHY 10 0.0011
672 DIARRHOEA 691 0.0011
673 INTESTINAL PERFORATION 12 0.0011
674 CHILLS 125 0.0011
675 VOMITING 501 0.0011
676 CHROMATURIA 24 0.0011
677 ABDOMINAL DISCOMFORT 178 0.0011
678 LIVER DISORDER 47 0.0011
679 DIALYSIS 15 0.0011
680 ANAPHYLACTIC SHOCK 27 0.0010
681 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
682 PULMONARY FIBROSIS 20 0.0010
683 PNEUMONIA ASPIRATION 26 0.0010
684 COVID-19 182 0.0010
685 HEAD DISCOMFORT 18 0.0010
686 CARDIOMYOPATHY 15 0.0010
687 RED BLOOD CELL COUNT DECREASED 29 0.0010
688 ARRHYTHMIA 48 0.0010
689 INTERSTITIAL LUNG DISEASE 49 0.0010
690 NAUSEA 800 0.0010
691 HEART RATE INCREASED 100 0.0010
692 MENTAL STATUS CHANGES 28 0.0010
693 BLINDNESS 41 0.0010
694 FATIGUE 781 0.0010
695 AGEUSIA 25 0.0010
696 VISUAL IMPAIRMENT 124 0.0010
697 PLATELET COUNT INCREASED 13 0.0010
698 BLOOD TEST ABNORMAL 14 0.0010
699 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17 0.0010
700 IMMUNE SYSTEM DISORDER 13 0.0010
701 LIVER FUNCTION TEST INCREASED 21 0.0010
702 DIARRHOEA HAEMORRHAGIC 9 0.0010
703 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
704 DRY MOUTH 78 0.0010
705 ARTERIOSCLEROSIS 9 0.0010
706 HYPOCALCAEMIA 18 0.0010
707 LOWER RESPIRATORY TRACT INFECTION 43 0.0009
708 PREMATURE DELIVERY 15 0.0009
709 SPLENOMEGALY 11 0.0009
710 GLOSSODYNIA 21 0.0009
711 POST PROCEDURAL COMPLICATION 18 0.0009
712 VIRAL INFECTION 31 0.0009
713 SYSTEMIC LUPUS ERYTHEMATOSUS 33 0.0009
714 BLOOD IRON DECREASED 11 0.0009
715 DYSURIA 34 0.0009
716 GASTROINTESTINAL HAEMORRHAGE 77 0.0009
717 PERITONITIS 19 0.0009
718 CELLULITIS 46 0.0009
719 ABDOMINAL PAIN 212 0.0009
720 RHABDOMYOLYSIS 38 0.0009
721 GASTROINTESTINAL PAIN 10 0.0009
722 ACUTE MYELOID LEUKAEMIA 14 0.0009
723 CARDIAC FAILURE 72 0.0009
724 BRAIN FOG 14 0.0009
725 DYSSTASIA 26 0.0009
726 TOXICITY TO VARIOUS AGENTS 149 0.0009
727 MITRAL VALVE INCOMPETENCE 10 0.0009
728 MICTURITION URGENCY 10 0.0009
729 VERTIGO 53 0.0009
730 HAEMATEMESIS 22 0.0009
731 NEURALGIA 21 0.0009
732 UNDERDOSE 63 0.0009
733 FEAR 23 0.0009
734 ABDOMINAL DISTENSION 89 0.0009
735 UNRESPONSIVE TO STIMULI 22 0.0009
736 INFLUENZA 95 0.0009
737 PANCREATITIS 45 0.0009
738 RASH GENERALISED 22 0.0008
739 SEASONAL ALLERGY 12 0.0008
740 HYPOTHYROIDISM 27 0.0008
741 CONFUSIONAL STATE 135 0.0008
742 INTENTIONAL PRODUCT MISUSE 73 0.0008
743 CHOLELITHIASIS 27 0.0008
744 SINUS CONGESTION 11 0.0008
745 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
746 SLEEP DISORDER 57 0.0008
747 PLATELET COUNT DECREASED 86 0.0008
748 HYPERSOMNIA 23 0.0008
749 OCULAR DISCOMFORT 9 0.0008
750 BLOOD POTASSIUM INCREASED 13 0.0008
751 HEPATIC CIRRHOSIS 15 0.0008
752 PROCEDURAL PAIN 22 0.0008
753 STOMATITIS 48 0.0008
754 PHOTOSENSITIVITY REACTION 13 0.0008
755 DYSPHAGIA 74 0.0008
756 MYDRIASIS 10 0.0008
757 HIP FRACTURE 25 0.0008
758 PANIC ATTACK 28 0.0008
759 IMPAIRED QUALITY OF LIFE 11 0.0008
760 DEVICE BREAKAGE 31 0.0008
761 APHASIA 23 0.0008
762 RASH PAPULAR 17 0.0008
763 ATAXIA 9 0.0008
764 DEPRESSED LEVEL OF CONSCIOUSNESS 30 0.0008
765 ABDOMINAL PAIN UPPER 156 0.0008
766 RASH 329 0.0008
767 CONJUNCTIVITIS 14 0.0008
768 CONVULSION 43 0.0008
769 HEPATIC STEATOSIS 14 0.0008
770 DEMENTIA 21 0.0008
771 LIP SWELLING 25 0.0007
772 DELIRIUM 26 0.0007
773 QUALITY OF LIFE DECREASED 10 0.0007
774 CARDIO-RESPIRATORY ARREST 31 0.0007
775 IMMUNODEFICIENCY 11 0.0007
776 LIMB INJURY 20 0.0007
777 MENTAL DISORDER 32 0.0007
778 DISORIENTATION 29 0.0007
779 PRODUCT PREPARATION ERROR 15 0.0007
780 ATRIAL FIBRILLATION 71 0.0007
781 HYPERCALCAEMIA 9 0.0007
782 CENTRAL NERVOUS SYSTEM LESION 10 0.0007
783 ADVERSE EVENT 67 0.0007
784 MELAENA 16 0.0007
785 GASTROENTERITIS VIRAL 13 0.0007
786 MOUTH ULCERATION 15 0.0007
787 EJECTION FRACTION DECREASED 11 0.0007
788 BLOOD PRESSURE DECREASED 47 0.0007
789 SINUS DISORDER 14 0.0007
790 THERAPY PARTIAL RESPONDER 11 0.0007
791 HYPERSENSITIVITY 129 0.0007
792 BALANCE DISORDER 60 0.0007
793 DEVICE DELIVERY SYSTEM ISSUE 19 0.0007
794 CYSTITIS 22 0.0007
795 FEELING ABNORMAL 165 0.0007
796 CARDIAC DISORDER 64 0.0007
797 WHITE BLOOD CELL COUNT DECREASED 74 0.0007
798 FEELING COLD 19 0.0007
799 FEELING JITTERY 13 0.0007
800 EYE DISORDER 22 0.0007
801 MUSCULAR WEAKNESS 76 0.0007
802 RASH PRURITIC 36 0.0007
803 OEDEMA 36 0.0007
804 VISUAL ACUITY REDUCED 22 0.0007
805 GASTROOESOPHAGEAL REFLUX DISEASE 53 0.0007
806 PERIPHERAL COLDNESS 9 0.0007
807 FOETAL EXPOSURE DURING PREGNANCY 53 0.0007
808 DIZZINESS 323 0.0006
809 GASTRITIS 17 0.0006
810 MUSCULOSKELETAL DISCOMFORT 11 0.0006
811 TREMOR 106 0.0006
812 NEUTROPHIL COUNT DECREASED 26 0.0006
813 DEHYDRATION 85 0.0006
814 PULMONARY EMBOLISM 60 0.0006
815 PROTEINURIA 12 0.0006
816 URINARY RETENTION 21 0.0006
817 HERPES ZOSTER 36 0.0006
818 SNEEZING 14 0.0006
819 MYELODYSPLASTIC SYNDROME 9 0.0006
820 ANOSMIA 9 0.0006
821 BRONCHITIS 46 0.0006
822 HALLUCINATION 46 0.0006
823 UPPER RESPIRATORY TRACT INFECTION 28 0.0006
824 HYPOAESTHESIA ORAL 9 0.0006
825 DYSPEPSIA 58 0.0006
826 SEIZURE 68 0.0006
827 HYPOPHAGIA 15 0.0006
828 CEREBRAL HAEMORRHAGE 21 0.0006
829 ARTHRITIS 46 0.0006
830 DIABETIC KETOACIDOSIS 14 0.0006
831 HEADACHE 365 0.0006
832 INSOMNIA 155 0.0006
833 ORAL PAIN 13 0.0006
834 PRODUCT USE ISSUE 109 0.0006
835 EXPOSURE DURING PREGNANCY 36 0.0006
836 CHRONIC KIDNEY DISEASE 44 0.0006
837 PRESYNCOPE 14 0.0006
838 URINARY TRACT INFECTION 98 0.0006
839 OEDEMA PERIPHERAL 70 0.0006
840 LETHARGY 33 0.0006
841 GAIT INABILITY 19 0.0006
842 MYALGIA 95 0.0006
843 POOR QUALITY SLEEP 12 0.0006
844 DISTURBANCE IN ATTENTION 30 0.0006
845 FAECES DISCOLOURED 12 0.0006
846 BLOOD PRESSURE ABNORMAL 11 0.0006
847 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 112 0.0006
848 PERIPHERAL SWELLING 84 0.0005
849 HAEMORRHAGE 57 0.0005
850 LOCALISED INFECTION 13 0.0005
851 SKIN EXFOLIATION 45 0.0005
852 BLOOD URINE PRESENT 10 0.0005
853 SOMNOLENCE 106 0.0005
854 GAIT DISTURBANCE 100 0.0005
855 PALPITATIONS 61 0.0005
856 HERNIA 10 0.0005
857 LOSS OF CONSCIOUSNESS 66 0.0005
858 FLATULENCE 29 0.0005
859 LABORATORY TEST ABNORMAL 15 0.0005
860 INTESTINAL OBSTRUCTION 19 0.0005
861 SKIN ULCER 13 0.0005
862 SINUSITIS 51 0.0005
863 HYPERTENSION 104 0.0005
864 ANAPHYLACTIC REACTION 27 0.0005
865 ANGINA PECTORIS 14 0.0005
866 PARAESTHESIA 76 0.0005
867 IRRITABILITY 29 0.0005
868 SWOLLEN TONGUE 15 0.0005
869 NERVOUSNESS 25 0.0005
870 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14 0.0005
871 MUSCLE TWITCHING 11 0.0005
872 AGITATION 35 0.0005
873 AMNESIA 31 0.0005
874 PRURITUS 183 0.0005
875 MATERNAL EXPOSURE DURING PREGNANCY 42 0.0005
876 BURNING SENSATION 33 0.0005
877 ERUCTATION 9 0.0005
878 WOUND 13 0.0005
879 THROMBOSIS 37 0.0005
880 EMOTIONAL DISORDER 14 0.0005
881 DYSARTHRIA 17 0.0005
882 BLOOD PRESSURE INCREASED 69 0.0005
883 INFLUENZA LIKE ILLNESS 37 0.0004
884 HYPOAESTHESIA 67 0.0004
885 CONSTIPATION 97 0.0004
886 HEART RATE IRREGULAR 10 0.0004
887 RECTAL HAEMORRHAGE 19 0.0004
888 SYNCOPE 44 0.0004
889 MOOD SWINGS 14 0.0004
890 ERYTHEMA 90 0.0004
891 VISION BLURRED 60 0.0004
892 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
893 RESPIRATORY ARREST 12 0.0004
894 NASOPHARYNGITIS 80 0.0004
895 INTENTIONAL PRODUCT USE ISSUE 38 0.0004
896 ASTHMA 49 0.0004
897 HEART RATE DECREASED 15 0.0004
898 NASAL CONGESTION 25 0.0004
899 CATARACT 25 0.0004
900 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
901 BONE PAIN 24 0.0004
902 CEREBRAL INFARCTION 10 0.0004
903 BACK PAIN 95 0.0004
904 EYE PAIN 23 0.0004
905 DEVICE USE ERROR 14 0.0004
906 ANXIETY 114 0.0004
907 RASH MACULAR 14 0.0004
908 URTICARIA 67 0.0004
909 CARDIAC FAILURE CONGESTIVE 32 0.0004
910 CARDIOVASCULAR DISORDER 10 0.0004
911 NECK PAIN 22 0.0004
912 THERAPY CESSATION 20 0.0004
913 NEOPLASM MALIGNANT 26 0.0004
914 LUNG NEOPLASM MALIGNANT 16 0.0004
915 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
916 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
917 HAEMATOMA 10 0.0004
918 ACCIDENTAL OVERDOSE 14 0.0004
919 MUSCULOSKELETAL PAIN 20 0.0004
920 INCORRECT DOSE ADMINISTERED BY DEVICE 10 0.0004
921 HYPERHIDROSIS 49 0.0004
922 URINARY INCONTINENCE 11 0.0004
923 NEPHROLITHIASIS 17 0.0004
924 FREQUENT BOWEL MOVEMENTS 10 0.0004
925 MOOD ALTERED 10 0.0004
926 BLOOD POTASSIUM DECREASED 11 0.0004
927 IMPAIRED HEALING 12 0.0004
928 OSTEONECROSIS 12 0.0004
929 LACRIMATION INCREASED 11 0.0004
930 DRY EYE 18 0.0004
931 FALL 120 0.0004
932 DRY SKIN 48 0.0004
933 ARTHRALGIA 149 0.0004
934 CRYING 13 0.0004
935 FLUID RETENTION 18 0.0004
936 INFUSION RELATED REACTION 23 0.0003
937 HAEMATOCHEZIA 19 0.0003
938 SPEECH DISORDER 18 0.0003
939 MUSCLE SPASMS 63 0.0003
940 ANHEDONIA 9 0.0003
941 OSTEOPOROSIS 14 0.0003
942 ANGIOEDEMA 15 0.0003
943 DEVICE DIFFICULT TO USE 22 0.0003
944 SKIN DISORDER 11 0.0003
945 DEPRESSION 75 0.0003
946 MEMORY IMPAIRMENT 45 0.0003
947 ECZEMA 17 0.0003
948 SWELLING FACE 21 0.0003
949 COGNITIVE DISORDER 15 0.0003
950 MOBILITY DECREASED 23 0.0003
951 PAIN IN JAW 9 0.0003
952 DIABETES MELLITUS 24 0.0003
953 THERAPEUTIC RESPONSE DECREASED 19 0.0003
954 DEPRESSED MOOD 16 0.0003
955 RESTLESSNESS 11 0.0003
956 SWELLING 28 0.0003
957 EYE IRRITATION 17 0.0003
958 DRUG EXPOSURE DURING PREGNANCY 10 0.0003
959 FEELING HOT 18 0.0003
960 POLLAKIURIA 12 0.0003
961 BLISTER 16 0.0003
962 HEAD INJURY 9 0.0003
963 OVERDOSE 61 0.0003
964 MYOCARDIAL INFARCTION 49 0.0003
965 DEEP VEIN THROMBOSIS 18 0.0003
966 EYE SWELLING 10 0.0003
967 PAIN IN EXTREMITY 79 0.0003
968 JOINT SWELLING 32 0.0003
969 PAIN 162 0.0003
970 ACCIDENTAL EXPOSURE TO PRODUCT 27 0.0003
971 ALOPECIA 51 0.0003
972 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
973 MALIGNANT NEOPLASM PROGRESSION 25 0.0002
974 MEDICATION ERROR 13 0.0002
975 PRODUCT STORAGE ERROR 20 0.0002
976 HOT FLUSH 17 0.0002
977 INCORRECT DOSE ADMINISTERED 51 0.0002
978 DYSKINESIA 9 0.0002
979 MIGRAINE 21 0.0002
980 WEIGHT INCREASED 49 0.0002
981 BLOOD GLUCOSE INCREASED 41 0.0002
982 BLOOD CHOLESTEROL INCREASED 10 0.0002
983 DISCOMFORT 12 0.0002
984 CEREBROVASCULAR ACCIDENT 33 0.0002
985 MUSCULOSKELETAL STIFFNESS 17 0.0002
986 BLOOD GLUCOSE DECREASED 9 0.0002
987 INJURY 13 0.0002
988 CONTUSION 16 0.0002
989 FLUSHING 16 0.0002
990 EMOTIONAL DISTRESS 18 0.0001
991 NO ADVERSE EVENT 22 0.0001
992 RHEUMATOID ARTHRITIS 11 0.0001
993 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000